What Causes Hyperpigmentation and How to Treat It – Your Complete Guide by AMA Regenerative Medicine & Skincare

Introduction: Understanding Skin Hyperpigmentation

Hyperpigmentation is one of the most common skin concerns, especially among individuals living in sunny climates like Southern California. Characterized by patches of skin becoming darker than the surrounding areas, hyperpigmentation can impact self-confidence and overall skin vitality. At AMA Regenerative Medicine & Skincare, we take a personalized, regenerative approach to treating hyperpigmentation safely and effectively.

What is Hyperpigmentation?

Hyperpigmentation occurs when excess melanin (the pigment responsible for skin color) forms deposits in the skin. While it is harmless, it often signals underlying skin imbalances that can be corrected through holistic treatments.

What Causes Hyperpigmentation?

Common Causes of Skin Discoloration:

Sun Exposure: UV rays accelerate melanin production, leading to sunspots or “age spots.”
Hormonal Changes: Pregnancy, birth control pills, and menopause can trigger melasma, resulting in light brown patches on the skin.
Post-Inflammatory Hyperpigmentation (PIH): Dark spots appear after acne, injuries, or cosmetic procedures.
Genetic Factors: Some individuals are genetically predisposed to small brown spots on skin.
Medications & Chemicals: Certain medications, including chemotherapy drugs, can cause skin discoloration.

Lesser-Known Causes:

Inflammatory Skin Conditions: Eczema and psoriasis may lead to residual dark patches.
Environmental Toxins: Pollution can damage skin and accelerate pigmentation issues.
Aging: Natural aging processes slow skin turnover, making discoloration more apparent.

Types of Hyperpigmentation

Melasma: Hormonal pigmentation, typically on the cheeks, forehead, and upper lip.
Sunspots (Lentigines): Dark, flat spots due to UV damage.
Post-Inflammatory Hyperpigmentation: Dark marks following skin injury or inflammation.
Freckles: Small brown spots often genetic and intensified by sun exposure.

How AMA Regenerative Medicine & Skincare Treats Hyperpigmentation

At AMA, we go beyond surface treatments by stimulating natural physiological healing processes.

Customized Laser Therapy Protocols:

Multi-Laser Approach: Simultaneous use of multiple lasers to target different pigmentation depths.
30+ State-of-the-Art Lasers: Pigment-targeting lasers, and gentle resurfacing tools.
Non-Invasive & Natural: Avoid harsh chemicals, opt for body-friendly regenerative treatments.

Regenerative & Holistic Treatments:

Nutritional & Lifestyle Support: Address hormonal imbalances and oxidative stress contributing to pigmentation.
IV Therapy: Skin-Bright IV with Copper – Boost collagen, accelerate skin repair, and promote youthful radiance.

Prevention Tips from AMA Experts

Daily Sunscreen: SPF 50+ to prevent future sun damage.
Antioxidant-Rich Skincare: Combat oxidative stress with high-quality serums.
Healthy Lifestyle: Balanced diet, hydration, and reduced stress for optimal skin health.

When to Consult AMA Regenerative Medicine & Skincare

If you notice persistent light brown patches on skin, dark spots, or worsening discoloration despite over-the-counter products, it’s time to consult with our expert team.

Our Promise:

Personalized Care Plans
Safe, Non-Toxic Treatments
Long-Term Skin Health Focus
Holistic Approach

Real Patient Success Stories

My melasma has dramatically lightened after just a few sessions. The multi-laser approach works wonders!
Lauren B., Los Angeles

After years of hiding my sun spots, AMA restored my confidence. The treatments are truly life-changing.
Maria R., Pomona

Take the First Step to Radiant Skin

Experience the AMA difference — book your personalized hyperpigmentation consultation today and discover your path to youthful, even-toned skin or visit us online at www.amaskincare.com

Disclaimer: This article is for educational purposes only. Consult a licensed medical professional before starting any treatment.

About the Authors

Alice Pien, MD & Asher Milgrom, PhD

Doctors Alice Pien, MD and Asher Milgrom, Phd are established pioneers in the fields of Regenerative Medicine and Skincare. Their expertise ranges from advanced laser systems to HCT/P – Stem Cell medicine. Their medical education and advanced certifications span from medical schools of NY State University, the University of Chicago, to Johns Hopkins, Harvard and UCLA. They approach medicine with the clinical expertise of over 85,000 successful treatments over the past 20 years and significant scientific research resulting in proprietary protocols that they customize for each individual patient.

References

Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 1997;29(3):315‐331. doi:10.1016/s0306-3623(96)00474-0
Beitner H. Randomized, placebo-controlled, double blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoageing of facial skin. Br J Dermatol. 2003;149(4):841‐849. doi:10.1046/j.1365-2133.2003.05597.x
Puizina-Ivić N, Mirić L, Carija A, Karlica D, Marasović D. Modern approach to topical treatment of aging skin. Coll Antropol. 2010;34(3):1145‐1153.
Sherif S, Bendas ER, Badawy S. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle. Eur J Pharm Biopharm. 2014;86(2):251‐259. doi:10.1016/j.ejpb.2013.09.008
Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One. 2010;5(9):e13058. Published 2010 Sep 28. doi:10.1371/journal.pone.0013058
Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29(11):2365‐2370. doi:10.2337/dc06-1216
Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic Acid. Front Pharmacol. 2011;2:69. Published 2011 Nov 17. doi:10.3389/fphar.2011.00069
Salehi B, Berkay Yılmaz Y, Antika G, et al. Insights on the Use of α-Lipoic Acid for Therapeutic Purposes. Biomolecules. 2019;9(8):356. Published 2019 Aug 9. doi:10.3390/biom9080356
Ghibu S, Richard C, Delemasure S, Vergely C, Mogosan C, Muresan A. Un dithiol endogène aux propriétés antioxydantes: l’acide alpha-lipoïque, utilisation potentielle dans les pathologies cardiovasculaires [An endogenous dithiol with antioxidant properties: alpha-lipoic acid, potential uses in cardiovascular diseases]. Ann Cardiol Angeiol (Paris). 2008;57(3):161‐165. doi:10.1016/j.ancard.2008.02.018
Silvestri S, Orlando P, Armeni T, et al. Coenzyme Q10 and α-lipoic acid: antioxidant and pro-oxidant effects in plasma and peripheral blood lymphocytes of supplemented subjects. J Clin Biochem Nutr. 2015;57(1):21‐26. doi:10.3164/jcbn.14-130
Skibska B, Goraca A. The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress. Oxid Med Cell Longev. 2015;2015:313021. doi:10.1155/2015/313021
Suh JH, Moreau R, Heath SH, Hagen TM. Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep. 2005;10(1):52‐60. doi:10.1179/135100005X21624
Berkson, Burton & Rubin, Daniel & Berkson, Arthur. (2009). Revisiting the ALA/N ( -Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases. Integrative cancer therapies. 8. 416-22. 10.1177/1534735409352082.
Di Geronimo G, Caccese AF, Caruso L, Soldati A, Passaretti U. Treatment of carpal tunnel syndrome with alpha-lipoic acid. Eur Rev Med Pharmacol Sci. 2009;13(2):133‐139.
Scaramuzza A, Giani E, Redaelli F, et al. Alpha-Lipoic Acid and Antioxidant Diet Help to Improve Endothelial Dysfunction in Adolescents with Type 1 Diabetes: A Pilot Trial. J Diabetes Res. 2015;2015:474561. doi:10.1155/2015/474561
Skibska B, Goraca A. The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress. Oxid Med Cell Longev. 2015;2015:313021. doi:10.1155/2015/313021